Generic Drug Conference
Executive Summary
Features 12 generic drug manufacturer presidents or CEOs who will speak about industry trends as well as their individual companies. Speakers include Barr Labs President Ed Cohen, Zenith Labs President/CEO John Klein, Teva Pharmaceutical CFO Dan Suesskind, IVAX Corp. President Jack Fishman, and Mylan Labs Chairman/CEO Roy McKnight. Sponsored by New York City-based investment banking firm Furman Selz, the conference begins at 7:45 a.m. April 16 at the New York Helmsley Hotel....
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth